Presentations at the 81st scientific sessions of the American Diabetes Association , part 2

The following summarizes presentations pertaining to sodium-glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), and chronic kidney disease (CKD) at the American Diabetes Association meeting, held virtually on 25-29 June 2021. Hamaguchi and coauthors treated 57 people with type 1 diabetes (T1D) with dapagliflozin, instructing those with basal to total daily insulin dose ratio >0.4 to reduce the basal...